Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 09:37 am Purchase | 2022-12-31 | 13G | KYMERA THERAPEUTICS INC KYMR | Avoro Capital Advisors LLC | 3,850,000 7.000% | 3,850,000 (New Position) | Filing History |
| 2023-02-09 11:25 am Purchase | 2022-12-30 | 13G | KYMERA THERAPEUTICS INC KYMR | VANGUARD GROUP INC | 3,660,307 6.670% | 703,133 (+23.78%) | Filing History |
| 2023-02-08 2:16 pm Purchase | 2022-12-31 | 13G | KYMERA THERAPEUTICS INC KYMR | STATE STREET CORPORATION STT | 2,846,221 5.190% | 2,846,221 (New Position) | Filing History |
| 2023-02-06 3:02 pm Purchase | 2022-12-30 | 13G | KYMERA THERAPEUTICS INC KYMR | Wellington Management Group LLP | 4,591,089 8.370% | 1,896,275 (+70.37%) | Filing History |
| 2023-02-01 4:54 pm Sale | 2022-12-31 | 13G | KYMERA THERAPEUTICS INC KYMR | BlackRock Inc. BLK | 3,334,901 6.100% | -62,639 (-1.84%) | Filing History |
| 2022-08-23 4:45 pm Purchase | 2022-08-22 | 13D | KYMERA THERAPEUTICS INC KYMR | BIOTECHNOLOGY VALUE FUND L P | 4,692,604 8.600% | 553,846 (+13.38%) | Filing History |
| 2022-07-11 2:10 pm Purchase | 2022-06-30 | 13G | KYMERA THERAPEUTICS INC KYMR | T. Rowe Price Associates, Inc. | 5,224,686 10.100% | 1,674,158 (+47.15%) | Filing History |
| 2022-06-01 5:00 pm Purchase | 2022-05-27 | 13D | KYMERA THERAPEUTICS INC KYMR | BIOTECHNOLOGY VALUE FUND L P | 4,138,758 8.000% | 552,100 (+15.39%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | KYMERA THERAPEUTICS INC KYMR | Redmile Group, LLC | 2,587,730 5.000% | -132,759 (-4.88%) | Filing History |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | KYMERA THERAPEUTICS INC KYMR | T. Rowe Price Associates, Inc. | 3,550,528 6.900% | 3,550,528 (New Position) | Filing History |
| 2022-02-11 5:09 pm Sale | 2021-12-31 | 13G | KYMERA THERAPEUTICS INC KYMR | Atlas Venture Fund X, L.P. | 5,763,012 11.200% | -2,185,970 (-27.50%) | Filing History |
| 2022-02-10 08:22 am Purchase | 2021-12-31 | 13G | KYMERA THERAPEUTICS INC KYMR | VANGUARD GROUP INC | 2,957,174 5.750% | 2,957,174 (New Position) | Filing History |
| 2022-02-09 09:22 am Sale | 2022-02-08 | 13G | KYMERA THERAPEUTICS INC KYMR | FMR LLC | 2,347,527 4.568% | -94,533 (-3.87%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | KYMERA THERAPEUTICS INC KYMR | BlackRock Inc. BLK | 3,397,540 6.600% | 3,397,540 (New Position) | Filing History |
| 2022-02-04 09:27 am Purchase | 2021-12-31 | 13G | KYMERA THERAPEUTICS INC KYMR | Wellington Management Group LLP | 2,694,814 5.240% | 2,694,814 (New Position) | Filing History |
| 2022-01-31 5:07 pm Purchase | 2022-01-27 | 13D | KYMERA THERAPEUTICS INC KYMR | BIOTECHNOLOGY VALUE FUND L P | 3,586,658 7.000% | 955,996 (+36.34%) | Filing History |